TXMD TherapeuticsMD, Inc.
Pharmaceutical Preparations · Nasdaq · SEC CIK 25743 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY33.9%
TTM net income YoY-59.6%
TTM EPS YoY-50.0%
Revenue 3-yr CAGR24.3%
Net income 3-yr CAGR-87.9%
Margins
Gross margin—
Operating margin-95.3%
Net margin3.3%
FCF margin—
EBITDA margin-85.1%
Returns
ROE0.4%
ROA0.3%
ROIC (approx.)-19.0%
Asset turnover0.10x
Leverage & solvency
Liabilities / assets27.2%
Debt / equity0.00x
Current ratio3.32x
Interest coverage—
Cash quality & payout
Operating cash flow / net income27.59x
Accruals ratio-8.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $3.02M | $1.76M |
| SG&A expense | $6.85M | $6.10M |
| Operating income | -$4.39M | -$6.11M |
| Interest expense | $8,000 | $10,000 |
| Pretax income | -$653,000 | -$2.34M |
| Income tax | — | -$31,000 |
| Net income | -$569,000 | -$2.18M |
| EBITDA | -$4.01M | -$5.60M |
| EPS (basic) | -0.05 | -0.19 |
| EPS (diluted) | -0.05 | -0.19 |
| Weighted avg. shares (diluted) | 11.57M | 11.53M |
| Balance sheet | ||
| Cash & equivalents | $7.48M | $5.06M |
| Current assets | $14.45M | $12.26M |
| Intangibles | $3.76M | $4.32M |
| Total assets | $37.66M | $38.82M |
| Current liabilities | $4.79M | $5.17M |
| Total liabilities | $10.78M | $11.45M |
| Shareholders' equity | $26.88M | $27.37M |
| Shares outstanding | 11.57M | 11.53M |
| Cash flow statement | ||
| Operating cash flow | $2.45M | $1.17M |
| Depreciation & amortization | $384,000 | $509,000 |
| Stock-based compensation | $75,000 | $264,000 |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.